Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Start for Free
/Free Sign Up
 0
💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair Value See Undervalued Stocks
Close

Merck KGaA ADR (MKKGY)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
36.913 +0.066    +0.18%
20:31:47 - Delayed Data. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 3,407
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 36.910 - 37.205
Merck ADR 36.913 +0.066 +0.18%

MKKGY Income Statement

 
Featured here, the Income Statement (earnings report) for Merck KGaA ADR, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Income Statement
Collapse All
Period Ending: 2024
30/06
 2024
31/03
 2023
31/12
 2023
30/09
Total Revenue 5352 5120 5225 5173
Revenue 5352 5120 5225 5173
Other Revenue, Total - - - -
Cost of Revenue, Total 2119 2111 2285 2162
Gross Profit 3233 3009 2940 3011
Total Operating Expenses 4559 4189 4517 4189
Selling/General/Admin. Expenses, Total 1482 1419 1418 1416
Research & Development 647 581 660 581
Depreciation / Amortization 447 454 -1318.4 431.2
Interest Expense (Income) - Net Operating -72 -74 - -84
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -64 -302 1472.4 -317.2
Operating Income 793 931 708 984
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - 132 -
Other, Net 8 32 -65 46
Net Income Before Taxes 785 899 641 938
Provision for Income Taxes 180 200 53 197
Net Income After Taxes 605 699 588 741
Minority Interest 67 78 75 73
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 607 694 586 739
Total Extraordinary Items - - - -
Net Income 607 694 586 739
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 607 694 586 739
Dilution Adjustment - - 2.29 -
Diluted Net Income 607 694 583.71 739
Diluted Weighted Average Shares 433.57 433.75 434.8 434.71
Diluted EPS Excluding Extraordinary Items 1.4 1.6 1.34 1.7
DPS - Common Stock Primary Issue - - 2.2 -
Diluted Normalized EPS 1.14 1.28 1.2 1.34
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

MKKGY Comments

Write your thoughts about Merck KGaA ADR
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Apple
Continue with Google
or
Sign up with Email